News
Oncological Drugs: Early Development from pre-clinics to phase II -...
www.agah.eu
Early development after having passed FIM, Manfred Klevesath, Darmstadt. Development options, expansion cohorts in Phase I and Phase II. 16:15: Practical aspects of early phase oncology trials – the oncologists view, Salah-Eddin Al-Batran, Frankfurt
Oncological Drugs: Early Development from pre-clinics to ...
www.agah.eu
— Break · Early development after having passed FIM, Manfred Klevesath, Darmstadt. Development options, expansion cohorts in Phase I and Phase II. › event › onc...
DFC 2021: Halbfinale - Initiative D21
initiatived21.de
— Dr. Manfred Klevesath, Head of Global Health, Bioethics and Digital Ethics, Corporate Affairs, Merck KGaA. › veranstaltungen › dfc-halbfinale
Merck ruft Digitalethik-Gremium ins Leben
www.merckgroup.com
— ... Healthcare und Life Science“, sagte Manfred Klevesath, Leiter Global Health, Bioethics and Digital Ethics bei Merck. A2H responsibility is led by Dr Petra Wicklandt, Head of. Corporate Affairs, and Dr Manfred Klevesath, Head of Global Health, Corporate Affairs. Access to ... › news › digital-ethics-ad... › OurApproach
sortiert nach Relevanz / Datum